EUVIMEDEUVIMED entdecken
Crossref

Nano-Diosmin mitigates EAC-induced renal injury through Nrf2-mediated antioxidant activation and NF-κB-dependent apoptotic suppression

Ahmad Najem Alshammari, Mohammed Saleh Alfawaz, Fatma Oraby, Ahmed M Mohamed, Ekramy M Elmorsy, Suzan S A Mohamed, Marwa M F Atta, Ali Ali El-Raghi

Medical Oncology · 2026

DOI: 10.1007/s12032-026-03387-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2026. Verfasst von Ahmad Najem Alshammari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Technology, College of Applied Medical Sciences, Northern Border University, 73213, Arar, Saudi Arabia. Hauptthemen laut MEDLINE: Carcinoma, Ehrlich Tumor, Apoptosis, Nanoparticles, NF-kappa B. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Northern Borders University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study provides the first evidence of the anticancer-associated renoprotective efficacy of diosmin (DI) delivered via chitosan nanoparticles (DI-CHNPs) in mice bearing Ehrlich ascites carcinoma (EAC). Sixty female Swiss albino mice were divided into six groups: controls, DI, DI-CHNPs, EAC, EAC+DI, and EAC+DI-CHNPs. Treatments involved DI or DI-CHNPs (100 mg/kg/day) for 20 days with or without tumor induction. DI-CHNPs significantly reduced tumor burden, as evidenced by lower body weight gain, abdominal circumference, tumor volume, and viable tumor cell count, and these effects were superior to free DI. DI-CHNPs also prolonged survival and improved renal function markers (urea, creatinine, electrolytes), indicating that attenuation of tumor progression was accompanied by reduced secondary renal injury. Antioxidant defenses in kidney tissues were strengthened through increased superoxide dismutase, catalase, glutathione peroxidase activities, and reduced glutathione levels, alongside reduced malondialdehyde. DI-CHNPs activated the Nrf2/HO-1/NQO1 pathway while down-regulated the inflammatory pathways controlling genes ( Tgfb 1, Nfkb 1, Il6 ) and pro-apoptotic markers ( Bax, Caspase−3 ), with increased Bcl-2 expression. Histopathological and ultrastructural analyses confirmed superior renal protection compared with DI. Molecular docking provided in silico supportive evidence for DI interaction with Nrf2, NF-κB, caspase−3, and TGF-β-related molecular targets involved in oxidative stress, inflammation, and apoptosis. Overall, the findings suggest that nanoparticle formulation enhanced the therapeutic performance of DI, likely through improved stability and sustained-release properties, resulting in superior antitumor efficacy and attenuation of tumor-associated renal injury. Graphical abstract An illustrated graphic described the nephroprotective effects of DI-CHNPs on Renal Injury and Tumor Burden in Ehrlich Ascites Carcinoma-Bearing Mice. DI-CHNPs treatment reduced tumor burden and improved renal function markers, including urea and creatinine. DI-CHNPs strengthened antioxidant defenses by elevating superoxide dismutase, catalase, and glutathione peroxidase activities, while increasing reduced glutathione and lowering malondialdehyde levels. Nrf2 signaling and downstream targets (HO-1 and NQO1) were activated. Concurrently, DI-CHNPs suppressed inflammatory mediators (TGF-β, NF-κB, IL-6) and pro-apoptotic markers (Bax, caspase−3), while enhancing Bcl-2 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Ehrlich TumorApoptosisNanoparticlesNF-kappa BAntioxidantsNF-E2-Related Factor 2DiosminAnimalsFemaleMiceOxidative StressKidneyChitosan

Stichwörter der Autor:innen

ApoptosisDI-CHNPsDiosmin-loaded chitosan nanoparticlesEhrlich ascites carcinomaOxidative stressRenoprotection

Substanzen

NF-kappa BAntioxidantsNF-E2-Related Factor 2DiosminNfe2l2 protein, mouseChitosan

Autor:innen und Institutionen

  • Department of Medical Laboratory Technology, College of Applied Medical Sciences, Northern Border University, 73213, Arar, Saudi Arabia.
  • Departmnet of Biochmeistry, Biochemistry Dept, Faculty of Medicine, Taif University, Taif, Saudi Arabia.
  • Department of Pharmacology, Collage of Medicine, Taif University, 821944, Taif, Saudi Arabia.
  • Center for Health Research, Northern Border University, 73213, Arar, Saudi Arabia.
  • Faculty of Applied Health Sciences Technology, October 6 University, 6Th of October City, Egypt.
  • Department of Biochemistry, Faculty of Veterinary Medicine, Egyptian Chinese University, Cairo, Egypt.

Förderung

  • Northern Borders University

Zitieren

APA

Alshammari, A. N., Alfawaz, M. S., Oraby, F., Mohamed, A. M., Elmorsy, E. M., Mohamed, S. S. A., Atta, M. M. F., & El-Raghi, A. A. (2026). Nano-Diosmin mitigates EAC-induced renal injury through Nrf2-mediated antioxidant activation and NF-κB-dependent apoptotic suppression. Medical Oncology. https://doi.org/10.1007/s12032-026-03387-3

Vancouver

Alshammari AN, Alfawaz MS, Oraby F, Mohamed AM, Elmorsy EM, Mohamed SSA, et al. Nano-Diosmin mitigates EAC-induced renal injury through Nrf2-mediated antioxidant activation and NF-κB-dependent apoptotic suppression. Medical Oncology. 2026. doi:10.1007/s12032-026-03387-3

BibTeX
@article{Alshammari2026,
  author = {Alshammari, Ahmad Najem and Alfawaz, Mohammed Saleh and Oraby, Fatma and Mohamed, Ahmed M and Elmorsy, Ekramy M and Mohamed, Suzan S A and Atta, Marwa M F and El-Raghi, Ali Ali},
  title = {Nano-Diosmin mitigates EAC-induced renal injury through Nrf2-mediated antioxidant activation and NF-κB-dependent apoptotic suppression},
  journal = {Medical Oncology},
  year = {2026},
  doi = {10.1007/s12032-026-03387-3}
}
Kostenlos starten →